Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?

Licht, Andrea S.; Murphy, Jill M.; Hyland, Andrew J.; Fix, Brian V.; Hawk, Larry W.; Mahoney, Martin C.
February 2010
Sexually Transmitted Infections;Feb2010, Vol. 86 Issue 1, p19
Academic Journal
Background Few studies have examined factors associated with the actual use of the human papillomavirus (HPV) vaccine since licensure in 2006. The aims of this study were to assess HPV vaccination rates and to examine whether knowledge and risk perceptions regarding HPV were associated with the reported use of the HPV vaccine among female college students. Methods Using a cross-sectional design, 406 women aged 18-26 years were recruited at two public universities and completed a self-administered survey. Respondents who reported having received at least one dose of HPV vaccine were classified as 'vaccinated' (n=177, 43.6%). Responses, stratified by the receipt of HPV vaccine, were compared using descriptive statistics and multivariate models. Results Based on multivariate logistic regression modelling, 18-year-old women were approximately four times more likely to report use of the HPV vaccine compared with respondents aged 19-26 years. Respondents who correctly indicated that HPV caused genital warts were 1.85 times more likely (adjusted odds ratio (OR) 1.85, 95% CI 1.20 to 2.93) to have received at least one HPV vaccine. African American and Asian women were each less likely to be vaccinated compared with white women. Risk perception was not significantly associated with vaccine uptake, however, the majority of respondents failed accurately to recognise their high risk of both acquiring and transmitting HPV. Conclusions These findings suggest knowledge deficits and misperceptions about HPV risk as potential themes for educational campaigns encouraging the greater use of the preventive HPV vaccine among this subgroup.


Related Articles

  • Human papillomavirus vaccine risk and reality. MacDonald, Noni; Stanbrook, Matthew B.; Hébert, Paul C. // CMAJ: Canadian Medical Association Journal;9/9/2008, Vol. 179 Issue 6, p503 

    The authors reflect on the lack of participation of students in school-based human papillomavirus (HPV) vaccine programs in Ontario. They point out that only about 50% of students in the province decided to have the HPV vaccine. They stress that one reason for the reluctance to receive the...

  • A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. Brabin, Loretta; Roberts, Stephen A.; Kitchener, Henry C. // BMC Public Health;2007, Vol. 7 Issue 1, p20 

    Background: The first vaccine to prevent human papillomavirus (HPV) and cervical cancer has been licensed, and in future, vaccination may be routinely offered to 10-14 year old girls. HPV is a sexually transmitted virus and some parents may refuse consent for vaccination. Under-16s in the UK...

  • Alternate HPV vaccine schedule for college students shows promise.  // Infectious Disease News;May2013, Vol. 26 Issue 5, p43 

    The article discusses research by Richard K. Zimmerman of the University of Pittsburgh and colleagues which examined the dosing schedule for human papillomavirus (HPV) vaccine in the college campus.

  • Appendix 2: Model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines.  // WHO Technical Report Series;2016, Issue 999, p232 

    An appendix is presented of model NRA Lot Release Certificate for recombinant human papillomavirus virus-like particle vaccines from the World Health Organization Expert Committee on Biological Standardization.

  • Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. Slade, Barbara A.; Leidel, Laura; Vellozzi, Claudia; Woo, Emily Jane; Wei Hua; Sutherland, Andrea; Izurieta, Hector S.; Ball, Robert; Miller, Nancy; Braun, M. Miles; Markowitz, Lauri E.; Iskander, John // JAMA: Journal of the American Medical Association;8/19/2009, Vol. 302 Issue 7, p750 

    The article focuses on a study which summarized data from the U.S. Vaccine Adverse Event Reporting System (VAERS) following receipt of recombinant human papillomavirus vaccine (qHPV). The qHPV reports received by VAERS from June 1, 2006 to December 31, 2008 were analyzed. A total of 12,424...

  • Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. Riethmuller, Didier; Jacquard, Anne-Carole; St Guily, Jean Lacau; Aubin, François; Carcopino, Xavier; Pradat, Pierre; Dahlab, André; Prétet, Jean-Luc // BMC Public Health;2015, Vol. 15 Issue 1, p1 

    Background: Human Papillomavirus (HPV) infection is known to be associated with a number of conditions including cervical, vaginal, vulvar, penile, anal neoplasias and cancers, oropharynx cancers and genitals warts (GW). Two prophylactic vaccines are currently available: a bivalent vaccine...

  • Statement on safety of HPV vaccine.  // WHO Drug Information;2008, Vol. 22 Issue 1, p13 

    The article reports on two cases of deaths in women who had previously received the Gardasil human papillomaviruses (HPV) vaccine in Europe. The European Medicines Agency (EMEA) revealed that they had received reports of death cases, sudden and unexpected deaths of two women who received the...

  • Estimation of the impact of genital warts on health-related quality of life. Woodhall, S.; Ramsey, T.; Cai, C.; Crouch, S.; Jit, M.; Birks, Y.; Edmunds, W. J.; Newton, R.; Lacey, C. J. N. // Sexually Transmitted Infections;Jun2008, Vol. 84 Issue 3, p161 

    Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV types 16 and 18. In anticipation of HPV vaccine implementation, the impact of genital warts on health-related...

  • The Risks and Benefits of HPV Vaccination. Haug, Charlotte // JAMA: Journal of the American Medical Association;8/19/2009, Vol. 302 Issue 7, p795 

    The author comments on the risks and beneficial effects of human papillomavirus (HPV) vaccine. She examines the theory behind the vaccine, and argues on the right vaccine that could prevent HPV infection. She discusses the two papers published which present significant data that may influence...

  • The Role of eHealth Literacy and HPV Vaccination Among Young Adults: Implications from a Planned Behavior Approach. Britt, Rebecca K.; Collins, W. Bart; Wilson, Kari M.; Linnemeier, Georgiann; Englebert, Andrew M. // Communication Research Reports;Jul-Sep2015, Vol. 32 Issue 3, p208 

    This article examines eHealth literacy and its association with HPV vaccination intention, specifically targeting young college students using the theory of planned behavior. A survey was distributed to 396 college students using the eHealth literacy scale and items from Ajzen's planned behavior...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics